Log In
Print
BCIQ
Print
Print this Print this
 

IMO-3100

  Manage Alerts
Collapse Summary General Information
Company Idera Pharmaceuticals Inc.
DescriptionDual toll-like receptor 7 (TLR7) and TLR9 antagonist
Molecular Target Toll-like receptor 7 (TLR7) ; Toll-like receptor 9 (TLR9)
Mechanism of ActionToll-like receptor 9 (TLR9) inhibitor; Toll-like receptor 7 (TLR7) inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today